Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001140361-20-011680
Filing Date
2020-05-14
Accepted
2020-05-14 20:54:04
Documents
4
Effectiveness Date
2020-05-14

Document Format Files

Seq Description Document Type Size
1 F-1MEF nt10009045x11_f1mef.htm F-1MEF 48162
2 EXHIBIT 5.1 nt10009045x11_ex5-1.htm EX-5.1 32214
3 EXHIBIT 23.1 nt10009045x11_ex23-1.htm EX-23.1 3145
4 nt10009045x11_ex5-1image01.jpg GRAPHIC 2690
  Complete submission text file 0001140361-20-011680.txt   88423
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-238280 | Film No.: 20880154
SIC: 2834 Pharmaceutical Preparations